Influence of successful psychopharmacotherapy of anxiety-depressive spectrum disorders on the severity of chronic fatigue in patients with rheumatoid arthritis

Influence of successful psychopharmacotherapy of anxiety-depressive spectrum disorders on the severity of chronic fatigue in patients with rheumatoid arthritis

Aim. To assess the influence of psychopharmacotherapy (PPT) of anxiety and depressive disorders on fatigue severity in patients with rheumatoid arthritis (RA). Materials and methods. 128 RA-patients were included. Severity of fatigue was measured with fatigue severity scale (FSS), clinically impo...

Full description

Bibliographic Details
Main Authors:	Anton A. Abramkin, Tatiana A. Lisitsyna, Dmitrii Y. Veltishchev, Olga F. Seravina, Oksana B. Kovalevskaya, Svetlana I. Glukhova, Evgeny L. Nasonov
Format:	Article
Language:	Russian
Published:	"Consilium Medicum" Publishing house 2021-05-01
Series:	Терапевтический архив
Subjects:	rheumatoid arthritis anxiety-depressive spectrum disorders chronic fatigue predictors, antidepressants
Online Access:	https://ter-arkhiv.ru/0040-3660/article/viewFile/71506/52263

Similar Items

Successful psychopharmacotherapy of anxiety and depressive disorders improve functional limitations in patients with rheumatoid arthritis
by: Anton A. Abramkin, et al.
Published: (2022-06-01)

Depression and severity of articular destruction in patients with rheumatoid arthritis
by: A. A. Abramkin, et al.
Published: (2020-06-01)

THE IMPACT OF ADEQUATE PSYCHOPHARMACOTHERAPY ON THE EFFICIENCY OF TREATMENT IN PATIENTS WITH RHEUMATOID ARTHRITIS
by: A. A. Abramkin, et al.
Published: (2018-05-01)

EFFECTS OF SYNTHETIC DISEASE-MODIFYING ANTIRHEUMATIC DRUGS, BIOLOGICAL AGENTS, AND PSYCHOPHARMACOTHERAPY ON THE MENTAL DISORDERS IN PATIENTS WITH RHEUMATOID ARTHRITIS
by: A. A. Abramkin, et al.
Published: (2017-09-01)

Chronic pain and depression in patients with rheumatoid arthritis: results of five - year follow - up
by: T A Lisitsyna, et al.
Published: (2019-05-01)

FACTORS INFLUENCING THE EFFICIENCY OF THERAPY IN PATIENTS WITH RHEUMATOID ARTHRITIS: THE ROLE OF COMORBID MENTAL AND SOMATIC DISEASES
by: A. A. Abramkin, et al.
Published: (2018-09-01)

Proinflammatory cytokines and depression in rheumatoid arthritis
by: Tatyana Andreyevna Lisitsyna, et al.
Published: (2013-06-01)

Psychopharmacotherapy for depression in rheumatic patients
by: N V Yaltzeva, et al.
Published: (2016-05-01)

Is improvement of fatigue in rheumatoid arthritis a proper effect of biologics?
by: Ines Mahmoud, et al.
Published: (2021-03-01)

Impact of tocilizumab therapy on fatigue in patients with rheumatoid arthritis
by: Anna Sergeyevna Starkova, et al.
Published: (2012-06-01)

Fatigue and sleep quality in rheumatoid arthritis patients during hospital admission
by: Paulina Szady, et al.
Published: (2017-04-01)

Assessment of correlation of fatigue in patients of rheumatoid arthritis using bristol rheumatoid arthritis fatigue multidimensional questionnaire score with disease activity – An Indian experience
by: Harpreet Singh, et al.
Published: (2023-01-01)

THE EFFECT OF ABATACEPT ON BLOOD BIOMARKERS IN PATIENTS WITH RHEUMATOID ARTHRITIS
by: M. A. Borisova, et al.
Published: (2017-09-01)

Depressive symptoms are associated with impaired sleep, fatigue, and disease activity in women with rheumatoid arthritis
by: Fernando Henrique Azevedo Lopes, et al.
Published: (2021-03-01)

The Assessment of Fatigue in Rheumatoid Arthritis Patients and Its Impact on Their Quality of Life
by: Waseem R. Dar, et al.
Published: (2022-07-01)

Adherence to Treatment in Patients with Rheumatoid Arthritis from Spain
by: Pombo-Suarez M, et al.
Published: (2021-01-01)

Prognostic Factors for Radiographic Progression in Patients with Seronegative Rheumatoid Arthritis
by: Eun-Jung Park, et al.
Published: (2021-03-01)

Adalimumab impact on fatigue measured by FACIT-F: a study of rheumatoid arthritis patients in Saudi Arabia
by: Janoudi N, et al.
Published: (2017-10-01)

Predictors of Response to (Etanercept) in the Treatment of Iraqi Patients with Active Rheumatoid Arthritis
by: Nizar A. Jassim
Published: (2015-04-01)

PREDICTION OF TOCILIZUMAB AND RITUXIMAB EFFECTIVENESS IN RHEUMATOID ARTHRITIS
by: Volkava M. V.
Published: (2019-11-01)

The Sustained Physical Activity Role in Overcoming Fatigue in Patients with Rheumatoid Arthritis
by: Andrey V. Aleksandrov, et al.
Published: (2022-04-01)

PROMIS Fatigue short forms are reliable and valid in adults with rheumatoid arthritis
by: Clifton O. Bingham III, et al.
Published: (2019-02-01)

Patient-reported fatigue in patients with rheumatoid arthritis who commence biologic therapy: a longitudinal study
by: Hege Selheim Rinke, et al.
Published: (2019-04-01)

Dynamic Characteristics and Predictive Profile of Glucocorticoids Withdrawal in Rheumatoid Arthritis Patients Commencing Glucocorticoids with csDMARD: A Real-World Experience
by: Wenhui Xie, et al.
Published: (2023-01-01)

Interleukin 6 as a pathogenic factor mediating clinical manifestations and a therapeutic target for rheumatic diseases and depressive disorders
by: T. A. Lisitsyna, et al.
Published: (2019-07-01)

Rheumatoid arthritis and sexuality: A patient survey in France
by: Kobelt Gisela, et al.
Published: (2012-09-01)

PULMONARY INVOLVEMENT IN RHEUMATOID ARTHRITIS
by: D. V. Bestaev, et al.
Published: (2014-09-01)

Use of antidepressants and benzodiazepine-related hypnotics before and after initiation of TNF-α inhibitors or non-biological systemic treatment in patients with rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitis
by: Philip Brenner, et al.
Published: (2020-02-01)

Rheumatoid Arthritis
by: Mahmood M.T.M. Ally, et al.
Published: (2016-03-01)

Quality of Life and Depression in Rheumatoid Arthritis Patients Treated with Biologics – A Single Centre Experience
by: Tański W, et al.
Published: (2022-03-01)

Rheumatoid arthritis and pseudo-vesicular skin plaques: rheumatoid neutrophilic dermatosis
by: Juan Manriquez, et al.
Published: (2016-08-01)

Predictors of mortality in patients with rheumatoid arthritis in Lithuania: Data from a cohort study over 10 years
by: Jolanta Dadonienė, et al.
Published: (2015-01-01)

NEW APPROACHES TO PHARMACOTHERAPY OF RHEUMATOID ARTHRITIS: TOFACITINIB
by: E. L. Nasonov
Published: (2014-06-01)

The Impact of Early Optimization of Infliximab Blood Concentrations >1 μg/mL on Therapeutic Effectiveness in Rheumatoid Arthritis
by: Yuji Nozaki, et al.
Published: (2023-04-01)

Fatigue in Systemic Lupus Erythematosus and Rheumatoid Arthritis: A Comparison of Mechanisms, Measures and Management
by: Mrinalini Dey, et al.
Published: (2021-08-01)

RHEUMATOID ARTHRITIS: THE PROBLEMS OF REMISSION AND THERAPY RESISTANCE
by: E. L. Nasonov, et al.
Published: (2018-07-01)

Hand and Wrist Involvement in Seropositive Rheumatoid Arthritis, Seronegative Rheumatoid Arthritis, and Psoriatic Arthritis—The Value of Classic Radiography
by: Ewa Żelnio, et al.
Published: (2023-03-01)

IMPACT OF COMORBID MENTAL DISORDERS ON THE EFFICIENCY OF THERAPY IN PATIENTS WITH RHEUMATOID ARTHRITIS
by: A. A. Abramkin
Published: (2016-07-01)

Editorial: Risk factors for Rheumatoid Arthritis and pre-Rheumatoid Arthritis
by: Emillie Sapart, et al.
Published: (2022-12-01)

PHARMACOTHERAPY FOR RHEUMATOID ARTHRITIS: NEW STRATEGY, NEW TARGETS
by: E. L. Nasonov
Published: (2017-09-01)